West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...
Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $225.00
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its price objective raised by The Goldman Sachs Group from $200.00 to $225.00 in a research note issued to investors on Thursday,Benzinga reports.
Is Takeda Pharmaceutical Company Limited (TAK) the Best Japanese Stock to Buy in 2025?
We recently compiled a list of the 12 Best Japanese Stocks To Buy in 2025. In this article, we are going to take a look at ...
Royalty Pharma: Delivering Growth With A Positive Story Ahead
Royalty Pharma's Q4 results show portfolio receipts of $742 million and operating cash flow of $678 million. Read why RPRX ...
Choreo LLC Takes $230,000 Position in Verona Pharma plc (NASDAQ:VRNA)
Choreo LLC bought a new position in Verona Pharma plc (NASDAQ:VRNA – Free Report) during the 4th quarter, according to the ...
S&P 500 Gains and Losses Today: MGM Stock Surges as Macau, Digital Businesses Thrive
The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of reciprocal ...
Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
West Pharmaceutical Services (WST) Bounced Back in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Craters on Stock Split before FDA Call
Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its ...